Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | POLQ | O75417 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29443546 | 1.00 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2CYP2D6CYP2C19POLB | |
| SCHEMBL17263229 | 0.87 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2CYP2D6CYP2C19POLB | |
| SCHEMBL15557360 | 0.84 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2HSD17B10NPSR1KMT2A | |
| SCHEMBL14307527 | 0.82 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2CYP2D6CYP2C19POLB | |
| SCHEMBL11336157 | 0.80 | POLB (0.38) | ALDH1A1SMN1; SMN2POLBTSHRHSD17B10 | |
| SCHEMBL5535038 | 0.79 | PGK1 (0.31) | — | |
| SCHEMBL5539664 | 0.78 | NFE2L2 (0.31) | NFE2L2 | |
| SCHEMBL254106 | 0.75 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2CYP2D6CYP2C19POLB | |
| SCHEMBL5706368 | 0.74 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2CYP2D6CYP2C19TSHR | |
| SCHEMBL29978275 | 0.74 | ALDH1A1 (0.33) | ALDH1A1NFE2L2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 436 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658652-A2 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4656639-A1 | METHOD FOR THE PREPARATION OF IBOGAMINE AND PURIFICATION OF IBOGAMINE AND IBOGAMINE-TYPE COMPOUNDS | Oeri, Hans (CA) | 2025-12-03 | — | — | EP | claimed |
| CN-119481273-A | Electrolyte, battery and electric equipment | 厦门海辰储能科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | claimed |
| WO-2024163626-A2 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2024-08-08 | — | — | WO | claimed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117352668-A | Preparation method of pyrophosphate secondary battery positive electrode material with high air stability | 深圳珈钠能源科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| EP-3694853-B1 | PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE | ARRAY BIOPHARMA INC (US) | 2023-05-17 | — | — | EP | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-109575060-B | Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction | 南开大学 | 2020-11-17 | — | — | CN | claimed |
| US-8404789-B2 | Olefin polymerization catalyst and preparation method and use thereof | PETROCHINA COMPANY LIMITED (CN) | 2013-03-26 | — | — | US | claimed |
| US-20110207900-A1 | CATALYST FOR HOMOPOLYMERIZING AND COPOLYMERIZING PROPYLENE AND ITS PREPARATION AND USE | PETROCHINA COMPANY LIMITED (CN) | 2011-08-25 | — | — | US | claimed |
| EP-2345675-A1 | A CATALYST FOR HOMOPOLYMERIZING AND COPOLYMERIZING PROPYLENE AND ITS PREPARATION AND USE | Petrochina Company Limited (CN) | 2011-07-20 | — | — | EP | claimed |
| US-20100184930-A1 | OLEFIN POLYMERIZATION CATALYST AND PREPARATION METHOD AND USE THEREOF | PETROCHINA COMPANY LIMITED (CN) | 2010-07-22 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | ANTXR2, AKR7A2, ACR | ALDH1A1 1295/4885SMN1; SMN2 3727/4885CYP2D6 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.